<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<title>8 Antibiotics - other drugs affecting cell walls</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<link href="../sgStyles2.css" rel="stylesheet" type="text/css">
		</csimport>
		<csimport user="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_568.incd" occur="46">
			
		</csimport>
	</head>

<body>
<a id="top"></a>

<div id="text">
		<div id="sumbox">
		
			<div id="drugbox">
			
			</div>
		</div>
		<p class="titleSG">Other drugs affecting cell walls</p>
		<input type="Button" value="Previous Page" onClick="history.go(-1)">
		<csobj csref="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_568.incd" h="672" occur="46" t="Component" w="974" g="incopy_default" s="">
			<p class="ParBodytext"><span style="font-weight: bold; ">Bacitracin</span> is a complex, cyclical polypeptide with 11 amino acids, isolated from <span style="font-style: italic; ">Bacillus subtilis</span>. There are over 15 different bacitracins, but bacitracin A is most po﻿tent. Commercial preparations tend to be a mixture of var﻿i﻿ous types. It is used as a production enhancer in the US, and to prevent necrotic enteritis in chickens in NZ but has been banned in Europe.</p>
			<p class="ParBodytext"></p>
			<p class="ParBodytext">It binds to isoprenyl phosphate in bacteria and pre﻿vents this from synthesising the glycopeptide units (N-acetyl glucuronic acid (NAG) - N-acetyl muraminic acid (NAM) pentapeptide isoprene pyrophosphate) produced for con﻿struc﻿tion of peptidoglycan. Bacitracin thereby in﻿hib﻿its bacterial cell wall synthesis. Divalent cations are required for activity, so bacitracin is often complexed with zinc.</p>
			<p class="ParBodytext"></p>
			<p class="ParBodytext">Bacitracin is primarily effective against Gram pos﻿i﻿tive bacteria including some <span style="font-style: italic; ">Staphylococcus </span>spp, <span style="font-style: italic; ">Strep﻿to﻿coc﻿cus </span>spp, <span style="font-style: italic; ">Haemophilus influenzae</span>, <span style="font-style: italic; ">Corynebacterium </span>spp, <span style="font-style: italic; ">Neisseria </span>spp, and <span style="font-style: italic; ">Clostridium </span>spp. It is not clinically effective against enteric Gram negative bacilli. Its main use is to prevent necrotic enteritis in chickens.</p>
			<p class="ParBodytext"></p>
			<p class="ParBodytext">Bacitracin has been around since 1947 and is used by the ton without major resistance developing. In﻿di﻿vid﻿u﻿al farms have problems with resistant <span style="font-style: italic; ">Cl perfringens</span> (chromosomally transmitted efflux pump?) which seems to disappear when bacitracin is not used for several batch﻿es of chickens. There is a suggestion that bacitracin may cause the expression of high level resistance to vancomycin in enterococci: this is probably not relevant clinically. Pol﻿i﻿tics are a different matter!</p>
			<p class="ParBodytext"></p>
			<p class="ParBodytext">Bacitracin complexes with lipids, including those of mammalian cell membranes, and when given sys﻿tem﻿i﻿cal﻿ly is severely nephrotoxic. Therefore, its use is limited to oral or topical application.</p>
			<p class="ParBodytext"></p>
			<p class="ParBodytext">Bacitracin is very poorly absorbed orally, and has been used for gastrointestinal sterilisation. There is no withholding time.</p>
			<p class="ParBodytext"></p>
			<p class="ParBodytext">It is also used in combination with other drugs in topical preparations, es?pe?cial?ly those intended for use in ears and eyes.</p>
		</csobj>

		
		<table width="90%" border="0" align="center">
  <tr>
				<td class="titleSG"><a href="abIndex.html" class="aTitle">8 Antibiotics index</a></td>
			</tr>
</table>
		<br>
<table width="90%" border="0" align="center">
  <tr align="center">
    <td>    <a href="../../indexpharm.html"><img src="../../PharmBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../toxSite/indexTox.html"><img src="../../ToxBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../indexSG.html"><img src="../../SGbut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../lectureSite/indexLec.html"><img src="../../LecBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../formSite/Aform.html" target="_blank"><img src="../../FormBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../casesSite/indexCases.html"><img src="../../CaseBut.gif" width="100" height="21" border="0"></a></td>
  </tr>
</table>
<br>
<table width="90%" border="0" align="center" cellpadding="2" cellspacing="0">
  <tr bgcolor="#FFFFFF">
    <td width="50%" class="commonname"><img src="../../pharmBits/images/mulogo.gif" width="170" height="25"></td>
    <td width="50%" align="right" class="references"><div align="right">copyright
        Massey University</div>
    </td>
  </tr>
</table>
<p>&nbsp;</p>
		<div id="gototop"><a href="#top"><b>top</b></a></div>

</div>
</body>
</html>
